Urogenital Tract Infection

Fig. 1.

Download original image
Best overall response to immune checkpoint inhibitor therapy. The antibiotics (ATB) use group showed an inferior disease control rate (56.3% vs. 13.3%, p=0.023) to the no ATB use group. PD: progressive disease, SD: stable disease, PR: partial response, CR: complete response.
Urogenit Tract Infect 2023;18:75-81 https://doi.org/10.14777/uti.2023.18.3.75
© 2023 Urogenit Tract Infect